In July, we (my wife and I) received a dividend income total of $2,836.82. 2023 was up 24%. 7 months down in 2024 and the S&P 500 is still up almost 13%, despite the recent sell-offs. We have a high likelihood of a rate cut in September, but too much speculation is happening beyond that date. Time is ticking on that FOMC meeting.

KINGSPORT, Tenn.--(BUSINESS WIRE)--Eastman has commenced a cash tender offer to purchase up to an aggregate principal amount of $250 million of its outstanding 3.800% Notes due 2025.

The sales volume of Eastman Chemical (EMN) in Q2 increases due to the end of customer inventory destocking in most end markets.

The headline numbers for Eastman Chemical (EMN) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Eastman Chemical (EMN) came out with quarterly earnings of $2.15 per share, beating the Zacks Consensus Estimate of $1.99 per share. This compares to earnings of $1.99 per share a year ago.

Plastics are one of the biggest culprits of environmental pollution. They take hundreds of years to decompose, contributing to the accumulation of waste in landfills and oceans.

Eastman (EMN) is expected to have benefited from cost-cutting and productivity initiatives as well as its innovation-driven growth strategy amid headwinds from soft demand in certain markets in Q2.

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Eastman Chemical (EMN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.

DuPont (DD), Eastman Chemical (EMN), Avient (AVNT) and Westlake (WLK) are likely to have benefited from cost and pricing actions as well as improved end-market demand on a moderation of de-stocking activities in Q2.

Eastman Chemical, Cabot and Kronos Worldwide have been highlighted in this Industry Outlook article.

Eastman Chemical (EMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Demand softness in specific markets, de-stocking and the slowdown in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. EMN, CBT and KRO are poised to navigate the industry challenges.